Friday, May 22, 2009

Triple Drug Combination Is Promising Option To Treat Metastatic HER2+ Breast Cancer

Combining two chemotherapy drugs with trastuzumab to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.
Full article >>

No comments:

Post a Comment